Acquisition of MacuVision

Alliance Pharma acquired MacuVision Europe for initial consideration of £5.5m and deferred contingent consideration of up to £6.0m earlier this month.

Solihull-based MacuVision sells MacuShield, an eye care treatment designed to be taken by sufferers of dry age-related macular degeneration and other eye conditions. MacuShield is a once-a-day capsule that contains meso-zeaxanthin, lutein and zeaxanthin - three carotenoids, or pigments.

Key marketing staff would transfer to Alliance from MacuVision and founders Trevor and Anne McCormack will continue their involvement in the business for twelve months, a statement added.